Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 104,426 $ 207,602
Short-term investments 81,725 15,483
Accounts receivable, net 10,196 12,778
Inventories 42,820 22,479
Contract assets 1,430 274
Prepaid expenses and other current assets 9,449 9,458
Total current assets 250,046 268,074
Property and equipment, net 12,438 10,046
Equipment on lease, net 9,601 8,366
Other assets 15,389 16,231
Total assets 287,474 302,717
Current liabilities:    
Accounts payable 19,609 9,882
Accrued expenses and other current liabilities 12,121 9,414
Debt – current portion 5,116 5,114
Contract liabilities 19,386 22,252
Total current liabilities 56,232 46,662
Long-term debt – less current portion 2,422 2,956
Contingent earnout liabilities (Note 10) 142,719 111,487
Warrant liabilities (Note 10) 27,719 21,705
Other noncurrent liabilities 8,778 9,492
Total liabilities 237,870 192,302
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Common stock, $0.00001 par value - 500,000,000 shares authorized at March 31, 2022 and December 31, 2021, 183,557,946 and 183,232,494 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively 2 2
Additional paid-in capital 345,418 340,294
Accumulated other comprehensive loss (608) (14)
Accumulated deficit (295,208) (229,867)
Total stockholders’ equity 49,604 110,415
Total liabilities and stockholders’ equity $ 287,474 $ 302,717